Sponsored Post, Patient Engagement

Why MedCity ENGAGE is 2015’s can’t-miss patient engagement conference

MedCity ENGAGE is one patient engagement conference with lessons that will endure well beyond the closing remarks.

This post is sponsored by MedCity ENGAGE.

We’re one month away from MedCity ENGAGE, MedCityNews.com’s patient engagement conference, and the full agenda is posted.

Patient engagement and healthcare delivery are the right place/right time topics of 2015. But there are things beyond the mere subject matter that should get you to ENGAGE on July 14-15 in Bethesda.

1. Networking that builds something greater. ENGAGE attendees will connect in unique ways and then, when the conference ends, contribute to a longer term discussion on the future of patient engagement.

Select attendees will take part in three workshops tasked to offer unique solutions to three major issues in patient engagement. The rest of the audience will vote on those ideas on Day 2, and the winning concept will be covered by the journalists at MedCity News for the rest of the year.

2. Patients Stories: From Beginning to End. Patients are peers at MedCity ENGAGE. Patients Kezia Fitzgerald, Carly Medosch and Garth Callaghan take the main stage to share their stories. But ENGAGE also features an ongoing video series throughout the conference of patients sharing their thoughts on how to improve medical care.

3. Realpolitik – not political talking points. ENGAGE breaks through political rhetoric and instead gets real insights from policymakers. Dr. Jon White from ONC, John J. Castellani from PhRMA, Oregon Sen. Elizabeth Steiner Hayward, former ONC director of consumer e-health Lygeia Ricciardi, and American Telemedicine Association policy advocate Gary Capistrant are among those who will offer policy critiques and perspectives from all angles.

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

4. All industries united. UnitedHealth and Humana. Kaiser Permanente and Kindred. Merck and Boehringer Ingelheim. Every sector of healthcare is coming to the table so there can be a complete conversation about how to solve the biggest challenges to improving patient relations and healthcare delivery.

Join the innovative leaders attending MedCity ENGAGE on July 14-15 in Bethesda.

Topics